Monomethyl fumarate - Isotope Labelled Standards
References
FAQ's
References
- Imam Pasha, S.; Varanasi, Murali Balaram; Mohammed, Ibrahim, Bioanalysis of monomethyl fumarate in human plasma by a sensitive and rapid LC-MS/MS method and its pharmacokinetic application LC-MS/MS determination of monomethyl fumarate in human plasma, Journal of Pharmaceutical and Biomedical Analysis, Volume: 146, Pages: 109-116, 2017 DOI: (1016/j.jpba.2017.08.015)
- Jirovsky, David; Wiegrebe, Wolfgang, HPLC-Analysis of Fumarates in Biological Matrices, Monatshefte fuer Chemie, Volume: 135, Issue: 12, Pages: 1563-1568, 2004 DOI: (10.1007/s00706-004-0230-6)
Frequently Asked Questions
What are the possible reasons for the formation of Monomethyl fumarate impurities?
Starting materials, reagents, unreacted catalysts during synthesis, and poor storage conditions may form Monomethyl fumarate impurities.
Why is it necessary to remove Monomethyl fumarate impurities from the drug?
Monomethyl fumarate impurities can affect drug safety and quality and pose health risks, so it is necessary to remove them from the drug.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.